Drugs / PregVit®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02300155 | Oct 2004 → Oct 2006 | hyperemesis gravidarum | The Hospital for Sick Children | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02300948 Comparator | Dec 2006 → Feb 2013 | pregnancy disorder | The Hospital for Sick Children | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pregvit | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02300155 ↗ |
| Modality | Other / unclassified | “A new periconceptional multivitamin supplement, Pregvit®, was introduced to the market in September 2003” NCT02300155 ↗ |
| Route | Oral | “Both supplements are taken as 2 tablets daily, one tablet in the morning (am) and one tablet in the evening (pm).” NCT02300948 ↗ |